Exploration of oxidative stress-mediated genetic toxicology modes of action using a pathway analysis, Connectivity

K Nadira De Abrew1, Bastian G Selman2, Mahmoud Shobair2

  • 1Ivorydale Innovation Center, The Procter & Gamble Company, Cincinnati, OH 45217, United States.

Insights

This study introduces a new genomic framework to identify genotoxic chemicals by analyzing oxidative stress mechanisms. The approach successfully distinguishes true genotoxicants from non-genotoxicants using in vitro data, advancing predictive toxicology.

Area of Science:

  • Toxicology and Genomics
  • Adverse Outcome Pathways (AOPs)
  • Predictive Toxicology

Background:

  • Current genetic toxicology methods lack the ability to identify the specific mode of action (MoA) of chemicals or differentiate between direct and indirect genotoxicants.
  • The Adverse Outcome Pathway (AOP) framework offers a structured approach to evaluate MoAs and dose-response relationships in genotoxicity.
  • Oxidative stress, involving reactive oxygen species (ROS), is a significant MoA linked to DNA damage and mutations.

Purpose of the Study:

  • To develop and validate a genomic framework for differentiating in vivo genotoxicants from non-genotoxicants.
  • To utilize the AOP for Oxidative DNA damage to investigate compounds with oxidative stress MoAs.
  • To establish a workflow for Next Generation Risk Assessment (NGRA) tools in predictive toxicology.

Main Methods:

  • Treatment of TK6 cells with 18 compounds exhibiting oxidative stress MoAs.
  • Application of genomic tools including Pathway analysis, Connectivity Mapping (CMap), and Transcriptional benchmark dose modeling.
  • Integration of in vitro micronucleus data to infer dose for genomic analyses.

Main Results:

  • A genomics-based workflow effectively separated in vivo genotoxicants from non-genotoxicants.
  • Pathway analysis generated hypotheses, which were subsequently tested using CMap and Transcriptional benchmark dose modeling.
  • The study demonstrates the utility of in vitro genomic data for predicting in vivo genotoxicity.

Conclusions:

  • A genomics-driven workflow, utilizing in vitro data, can successfully classify substances based on their in vivo genotoxic potential.
  • This approach has the potential to enhance the accuracy and efficiency of genotoxicity testing.
  • The developed framework supports the advancement of predictive toxicology and NGRA tools for assessing oxidative stress-related MoAs.